Morphometric and Functional Changes in Epicardial Adipose Tissue Adipocytes in Coronary Atherosclerosis: Relationship with Inflammatory and Metabolic Parameters and Triglyceride Levels
https://doi.org/10.18087/cardio.2025.9.n2987
Abstract
Aim To study the relationship between adipocyte size and reactive oxygen species (ROS) production in epicardial/subcutaneous adipose tissue (EAT/SAT) with metabolic and inflammatory markers in patients with ischemic heart disease (IHD) undergoing coronary artery bypass grafting (CABG).
Material and methods The study included 46 patients (32 men, 14 women) aged 45-72 years with IHD and coronary atherosclerosis, who had indications for CABG. Adipocytes from EAT and SAT obtained intraoperatively served as the material. The average size of adipocytes in EAT and SAT and the degree of their hypertrophy were determined; the level of ROS in adipocytes was assessed in 38 patients. The state of blood lipid transport function, glucose/insulin metabolism, the content of adipokines, and inflammatory biomarkers were studied, and surrogate indices of insulin resistance (IR) were calculated.
Results The average size of EAT adipocytes, in contrast to SAT adipocytes, correlated with serum concentrations of tumor necrosis factor-α (TNF-α) (rs=0.43), basal C-peptide (rs=0.40), triglycerides (TG) (rs=0.36), adiponectin (rs=0.34), interleukin-1β (IL-1β) (rs=0.29) and the TyG index (rs=0.32). ROS production by EAT adipocytes correlated with the concentrations of resistin (rs=0.39), TG (rs=0.35), adiponectin (rs=–0.34), and the TyG index (rs=0.35). The following independent determinants of increased ROS production by EAT adipocytes were identified: blood concentrations of TG, TNF-α, and resistin. A threshold TG level of 1.44 mM was determined, which was associated with ROS production by EAT adipocytes above the first tertile. Increased blood TG concentrations ≥1.44 mM were associated with increased EAT adipocyte hypertrophy, ROS production, a more atherogenic dyslipoproteinemic profile, higher IL-1β levels, IR indices, and lower adiponectin concentration.
Conclusion For the first time it was shown that in patients with coronary atherosclerosis, elevated TG levels and the TyG index are independently associated with abnormal morphometry of EAT adipocytes and their dysfunction is manifested by increased ROS production. Combined blood levels of TG, resistin, and TNF-α serve as independent determinants of ROS production by EAT adipocytes. Blood TG concentrations ≥1.44 mM are associated with activation of oxidative stress in EAT adipocytes, exacerbation of IR, adipokine imbalance, and low-grade inflammation. These findings support the need to identify optimal TG concentrations in patients with IHD and coronary atherosclerosis.
Keywords
About the Authors
O. A. KoshelskayaRussian Federation
M.D., Ph.D., Dr. Sci. (Med.), Prof., the Leading Research Fellow of the Department of Atherosclerosis and Coronary Artery Disease,
Tomsk, Russia
E. S. Kravchenko
Russian Federation
Junior Research Fellow, Department of Clinical Laboratory Diagnostics
Tomsk, Russia
N. V. Naryzhnaya
Russian Federation
Leading Researcher, Laboratory of Experimental Cardiology
Tomsk, Russia
I. V. Kologrivova
Russian Federation
Dr. Sci. (Med.), Senior Research Fellow, Department of Clinical Laboratory Diagnostics
Tomsk, Russia
O. A. Kharitonova
Russian Federation
Junior Research Fellow of the Department of Atherosclerosis and Coronary Artery Disease
Tomsk, Russia
V. V. Evtushenko
Russian Federation
M.D., Ph.D., Dr. Sci. (Med.), Doctor of the Department of Cardiovascular Surgery No. 1
Tomsk, Russia
N. V. Rebrova
Russian Federation
Head of the Department, Department of Atherosclerosis and Coronary Artery Disease
Tomsk, Russia
T. E. Suslova
Russian Federation
Ph.D., Head of the Department, Department of Clinical Laboratory Diagnostics,
Tomsk, Russia
References
1. Akhigbe R, Ajayi A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids in Health and Disease. 2021;20(1):23. DOI: 10.1186/s12944-021-01435-7
2. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation. 2004;114(12):1752–61. DOI: 10.1172/JCI21625
3. Maslov LN, Naryzhnaya NV, Boshchenko AA, Popov SV, Ivanov VV, Oeltgen PR. Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome? Journal of Clinical & Translational Endocrinology. 2019;15:1–5. DOI: 10.1016/j.jcte.2018.11.001
4. Koshelskaya O.A., Naryzhnaya N.V., Kologrivova I.V., Suslova T.E., Kharitonova O.A., Evtushenko V.V. et al. The level of reactive oxygen species production by adipocytes of epicardial adipose tissue is associated with an increase in postprandial glycemia in patients with severe coronary atherosclerosis. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(3):59–67. DOI: 10.29001/2073-8552-2021-36-3-59-67
5. Naryzhnaya NV, Koshelskaya OA, Kologrivova IV, Suslova TE, Kharitonova OA, Andreev SL et al. Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis. Biomedicines. 2022;10(8):2054. DOI: 10.3390/biomedicines10082054
6. Braescu L, Sturza A, Aburel OM, Sosdean R, Muntean D, Luca CT et al. Assessing the Relationship between Indexed Epicardial Adipose Tissue Thickness, Oxidative Stress in Adipocytes, and Coronary Artery Disease Complexity in Open-Heart Surgery Patients. Medicina. 2024;60(1):177. DOI: 10.3390/medicina60010177
7. González P, Lozano P, Ros G, Solano F. Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections. International Journal of Molecular Sciences. 2023;24(11):9352. DOI: 10.3390/ijms24119352
8. Akhmedzhanov N.M., Butrova S.A., Dedov I.I., Zvenigorodskaya L.A., Kislyak O.A., Koshelskaya O.A. et al. Russian experts’ consensus on metabolic syndrome problem in the Russian Federation: definition, diagnostic criteria, primary prevention, and treatment. Cardiovascular Therapy and Prevention. 2010;9(5):4–11.
9. Koshelskaya O.A., Kravchenko E.S., Naryzhnaya N.V., Kologrivova I.V., Krapivina A.S., Haritonova O.A. et al. Adipocytes Size of the Epicardial Adipose Tissue in Patients With Coronary Artery Disease and Coronary Atherosclerosis: Relationship With Parameters of Blood Lipid Transport Function, Carbohydrate Metabolism and Inflammatory Markers. Kardiologiia. 2024;64(9):48–57. DOI: 10.18087/cardio.2024.9.n2691
10. Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nature Reviews Cardiology. 2022;19(9):593–606. DOI: 10.1038/s41569-022-00679-9
11. Salgado-Somoza A, Teijeira-Fernández E, Fernández ÁL, GonzálezJuanatey JR, Eiras S. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. American Journal of Physiology-Heart and Circulatory Physiology. 2010;299(1):H202–9. DOI: 10.1152/ajpheart.00120.2010
12. Rabkin SW. Epicardial Adipose Tissue and Reactive Oxygen Species. Systems Biology of Free Radicals and Antioxidants. 2014;1:1021-30. DOI: 10.1007/978-3-642-30018-9_47
13. Dozio E, Vianello E, Briganti S, Fink B, Malavazos AE, Scognamiglio ET et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brownto-white adipocyte trans-differentiation. International Journal of Cardiology. 2014;174(2):413–4. DOI: 10.1016/j.ijcard.2014.04.045
14. Bespalova I.D., Kalyuzhin V.V., Murashev B.Yu., Osikhov I.A., Koshchavtseva Yu.I., Teteneva A.V. et al. Subpopulation composition and prooxidant activity of visceral adipose tissue cells in patients with metabolic syndrome. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(3):114–20. DOI: 10.29001/2073-8552-2022-37-3-114-120
15. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944–8. DOI: 10.1038/nature04634
16. Monickaraj F, Aravind S, Nandhini P, Prabu P, Sathishkumar C, Mohan V et al. Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. Journal of Biosciences. 2013;38(1):113–22. DOI: 10.1007/s12038-012-9289-0
17. Issa N, Lachance G, Bellmann K, Laplante M, Stadler K, Marette A. Cytokines promote lipolysis in 3T3-L1 adipocytes through induction of NADPH oxidase 3 expression and superoxide production. Journal of Lipid Research. 2018;59(12):2321–8. DOI: 10.1194/jlr.M086504
18. Abou-Rjeileh U, Contreras GA. Redox Regulation of Lipid Mobilization in Adipose Tissues. Antioxidants. 2021;10(7):1090. DOI: 10.3390/antiox10071090
19. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid–induced insulin resistance. Journal of Clini cal Investigation. 2006;116(11):3015–25. DOI: 10.1172/JCI28898
20. Park HK, Kwak MK, Kim HJ, Ahima RS. Linking resistin, inflammation, and cardiometabolic diseases. The Korean Journal of Internal Medicine. 2017;32(2):239–47. DOI: 10.3904/kjim.2016.229
21. Luo J, Huang L, Wang A, Liu Y, Cai R, Li W et al. Resistin-Induced Endoplasmic Reticulum Stress Contributes to the Impairment of Insulin Signaling in Endothelium. Frontiers in Pharmacology. 2018;9:1226. DOI: 10.3389/fphar.2018.01226
22. Foley KP, Chen Y, Barra NG, Heal M, Kwok K, Tamrakar AK et al. Inflammation promotes adipocyte lipolysis via IRE1 kinase. Journal of Biological Chemistry. 2021;296:100440. DOI: 10.1016/j.jbc.2021.100440
23. Kameji H, Mochizuki K, Miyoshi N, Goda T. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α. Nutrition. 2010;26(11–12):1151–6. DOI: 10.1016/j.nut.2009.09.006
24. Russian Society of Cardiology. Clinical recommendations. Violation of lipid metabolism. 2023. Av. at: http://scardio.ru/content/Guidelines/KR_NLO_2023.pdf.
25. Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies – a consensus statement from the European Atherosclerosis Society. European Heart Journal. 2021;42(47):4791–806. DOI: 10.1093/eurheartj/ehab551
26. Aberra T, Peterson ED, Pagidipati NJ, Mulder H, Wojdyla DM, Philip S et al. The association between triglycerides and incident cardiovascular disease: What is “optimal”? Journal of Clinical Lipidology. 2020;14(4):438-447.e3. DOI: 10.1016/j.jacl.2020.04.009
27. Kristensen FPB, Christensen DH, Mortensen MB, Maeng M, Kahlert J, Sørensen HT et al. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study. Cardiovascular Diabetology. 2023;22(1):187. DOI: 10.1186/s12933-023-01921-5
28. Ueno H, Saitoh Y, Mizuta M, Shiiya T, Noma K, Mashiba S et al. Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome. Obesity Research & Clinical Practice. 2011;5(4):e267-360. DOI: 10.1016/j.orcp.2011.03.012
29. Acharya P, Talahalli RR. Aging and Hyperglycemia Intensify Dyslipidemia-Induced Oxidative Stress and Inflammation in Rats: Assessment of Restorative Potentials of ALA and EPA + DHA. Inflammation. 2019;42(3):946–52. DOI: 10.1007/s10753-018-0949-6
Review
For citations:
Koshelskaya O.A., Kravchenko E.S., Naryzhnaya N.V., Kologrivova I.V., Kharitonova O.A., Evtushenko V.V., Rebrova N.V., Suslova T.E. Morphometric and Functional Changes in Epicardial Adipose Tissue Adipocytes in Coronary Atherosclerosis: Relationship with Inflammatory and Metabolic Parameters and Triglyceride Levels. Kardiologiia. 2025;65(9):26-35. (In Russ.) https://doi.org/10.18087/cardio.2025.9.n2987










